Prescription products · Product label record
Liraglutide community
LIRAGLUTIDE
Cipla USA Inc. · SUBCUTANEOUS
About this product community
Discuss Liraglutide supplied by Cipla USA Inc. for the subcutaneous route. Product codes: 69097-920. Check the name, labeler and route on your packaging before comparing experiences.
Forms and strengths in the label: 3 DOSAGE FORMS AND STRENGTHS Injection: 18 mg/3 mL (6 mg/mL) clear, colorless solution in a prefilled, single-patient-use pen that delivers doses of 0.6 mg, 1.2 mg, or 1.8 mg. Injection: 6 mg/mL solution in a prefilled, single-patient-use pen that delivers doses of 0.6 mg, 1.2 mg, or 1.8 mg. ( 3 ) Read the source section
Useful topics include starting treatment, everyday routines, side effects you discussed with your clinician, and access to this product. This space has no patient rating until a visitor submits a review.
Related ingredient communities: Liraglutide.
Read 27 sections from the product label · Original label on DailyMedCommunity conversations
Start a conversationBe the first to share your experience
No patient contributions yet. Start a conversation about this specific product.
No posts in this category yet. Your experience could help the next person.